AVEO Pharmaceuticals, Inc. withdraws earnings guidance for the year 2022. Due to the pending transaction, the company will not host a conference call to discuss its quarterly financial results and withdraws its previously issued financial guidance for fiscal year 2022, last updated on August 4, 2022.